← Leaderboards
Thomas W Glover
University Of Michigan At Ann Arbor
$8,714,896
Attributed
$11,167,758
Total exposure
8
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $830.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,167,758 · 8
By mechanism
R01$10,182,257 · 6
RC1$985,501 · 1
M01$0 · 1
Top collaborators
- Thomas Edward Wilson10 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Thomas Edward Wilson$9,654,214
- Elizabeth R Lawlor$9,932,316
- Maria G Castro$22,126,725
- Chris J Dickinson$1,134,005
- Ashley Melnick$91,535
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesMutationMonitorGenomicsStressHereditary DiseaseCellsIn VivoResolutionTissuesDna RepairCopy Number PolymorphismMalignant NeoplasmsHydroxyureaBiological ModelsStructureGene ExpressionVariantCell Culture TechniquesGenetic PolymorphismMitoticMouse ModelCell CycleChromosome Fragile Sites
Grant awards (33)
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication$494,161
R01 · FY2025 · GM
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication$494,161
R01 · FY2024 · GM
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication$516,470
R01 · FY2023 · GM
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome$485,226
R01 · FY2020 · CA
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome$470,668
R01 · FY2019 · CA
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome$485,226
R01 · FY2018 · CA
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome$489,085
R01 · FY2017 · CA
Extreme genomic instability at large transcribed genes: mechanisms and consequences for the cancer genome$485,226
R01 · FY2016 · CA
De novo CNV formation in vivo with sickle cell anemia therapy$345,028
R01 · FY2016 · ES · contact PI
De novo CNV formation in vivo with sickle cell anemia therapy$376,357
R01 · FY2015 · ES · contact PI
De novo CNV formation in vivo with sickle cell anemia therapy$116,266
R01 · FY2015 · ES · contact PI
De novo CNV formation in vivo with sickle cell anemia therapy$379,559
R01 · FY2014 · ES · contact PI
De novo CNV formation in vivo with sickle cell anemia therapy$364,296
R01 · FY2013 · ES · contact PI
De novo CNV formation in vivo with sickle cell anemia therapy$375,981
R01 · FY2012 · ES · contact PI
Environmental Risk Factors for Copy Number Variation in Human Chromosomes$499,886
RC1 · FY2010 · ES · contact PI
Environmental Risk Factors for Copy Number Variation in Human Chromosomes$485,615
RC1 · FY2009 · ES · contact PI
Role of Fragile Sites in Chromosome Breakage and Cancer$40,634
R01 · FY2008 · CA · contact PI
Role of Fragile Sites in Chromosome Breakage and Cancer$313,966
R01 · FY2007 · CA · contact PI
FOXC2 in Hereditary Lymphedema and Lymphatic Development$38,000
R01 · FY2007 · HL · contact PI
Role of Fragile Sites in Chromosome Breakage and Cancer$323,343
R01 · FY2006 · CA · contact PI
FOXC2 in Hereditary Lymphedema and Lymphatic Development$402,650
R01 · FY2005 · HL
Role of Fragile Sites in Chromosome Breakage and Cancer$331,124
R01 · FY2005 · CA
FOXC2 in Hereditary Lymphedema and Lymphatic Development$397,301
R01 · FY2004 · HL
Role of Fragile Sites in Chromosome Breakage and Cancer$331,124
R01 · FY2004 · CA
FOXC2 in Hereditary Lymphedema and Lymphatic Development$384,337
R01 · FY2003 · HL
Role of Fragile Sites in Chromosome Breakage and Cancer$330,142
R01 · FY2003 · CA
FOXC2 in Hereditary Lymphedema and Lymphatic Development$383,182
R01 · FY2002 · HL
FRAGILE SITES AND CHROMOSOME BREAKAGE AND CANCER$281,657
R01 · FY2002 · CA
MOLECULAR BIOLOGY OF THE MENKES SYNDROME GENE$0
M01 · FY2002 · RR
FRAGILE SITES AND CHROMOSOME BREAKAGE AND CANCER$273,452
R01 · FY2001 · CA
FRAGILE SITES AND CHROMOSOME BREAKAGE AND CANCER$265,486
R01 · FY2000 · CA
MOLECULAR BIOLOGY OF THE MENKES SYNDROME GENE$208,149
R01 · FY2000 · DK
MOLECULAR BIOLOGY OF THE MENKES SYNDROME GENE$0
M01 · FY2000 · RR